Abbott's New HIV-1 Qualitative Assay Improves Testing Access in Remote Areas for Children and Adults
25-03-2011: Abbott announced that it has received CE-Mark for a new qualitative PCR-based HIV-1 test that produces highly accurate results from dried blood spot and plasma specimens. The new assay is a long-awaited diagnostic tool for health officials in African nations and other resource-limited areas to detect HIV-1 infected infants at early stages and begin treatment when success is more likely.
Abbott's RealTime HIV-1 Qualitative Assay is performed on Abbott's automated, high-throughput m2000 system, which is used in laboratories worldwide. The highly sensitive assay detects both DNA and RNA of HIV-1. Dried blood spot samples are more convenient for testing infants because only a small volume of sample is needed and the sample remains stable under various environmental conditions.
The new RealTime HIV-1 Qualitative Assay will be available for diagnostic laboratories and supplied to non-governmental organizations and health agencies collaborating with the Ministries of Health in countries most affected by the epidemic.
"This test is a welcome advancement in the ongoing effort to detect pediatric HIV infections in Africa," said Kristina Rodnikova, divisional vice president and general manager of Abbott's molecular diagnostics business in Europe. "Early detection of infants with HIV is now more practical and possible in remote areas because a drop of blood can be applied to a paper card for HIV testing, which allows for easy collection, transport, and storage. The sample can be stored at room temperature and will remain stable for three months."
- 1Analytik Jena AG Signs Agreement to Acquire Bruker's ICP-MS Business
- 2Schleicher & Schuell has been purchased by Whatman plc
- 3Food analysis and diagnostics are hot topics at analytica China 2014
- 4Analytik Jena Closed Third Quarter Below Expectations
- 5SGS appoints new Chief Financial Officer
- 6The shadow of a disease
- 7Faster, cheaper tests for sickle cell
- 8Malvern Instruments acquires assets of Reologica Instruments AB
- 9DKSH exclusively distributes Postnova Analytics’ Field-Flow Fractionation systems
- 10Malvern Instruments completes acquisitions
- New Filter Technology – Uses Inert Gas to Bore Holes in High-Quality Steel
- QIAGEN adds promising genomic biomarkers to pipeline
- A Toxic-Free Alternative: Rigorous Assay of Chloride and Sulfate in Adenosine
- Studies Validate EKF Diagnostics’ Early Stage Test for Progressive Diabetic ...
- Evotec receives first milestone in Roche biomarker collaboration